Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.971 |
High Similarity |
NPD4584 |
Approved |
0.9704 |
High Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.9241 |
High Similarity |
NPD7298 |
Approved |
0.9028 |
High Similarity |
NPD3641 |
Approved |
0.9028 |
High Similarity |
NPD3640 |
Phase 3 |
0.9028 |
High Similarity |
NPD3639 |
Approved |
0.8904 |
High Similarity |
NPD4017 |
Approved |
0.8784 |
High Similarity |
NPD4772 |
Phase 2 |
0.8784 |
High Similarity |
NPD4773 |
Phase 2 |
0.8639 |
High Similarity |
NPD6031 |
Approved |
0.8639 |
High Similarity |
NPD6030 |
Approved |
0.8551 |
High Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.8535 |
High Similarity |
NPD8099 |
Discontinued |
0.8535 |
High Similarity |
NPD8251 |
Approved |
0.8535 |
High Similarity |
NPD8252 |
Approved |
0.8521 |
High Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.8521 |
High Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.8506 |
High Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.8489 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.8481 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.8452 |
Intermediate Similarity |
NPD6107 |
Approved |
0.8435 |
Intermediate Similarity |
NPD3124 |
Discontinued |
0.8397 |
Intermediate Similarity |
NPD4010 |
Discontinued |
0.8299 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.828 |
Intermediate Similarity |
NPD4166 |
Phase 2 |
0.8217 |
Intermediate Similarity |
NPD7802 |
Discontinued |
0.8214 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD6896 |
Approved |
0.8194 |
Intermediate Similarity |
NPD6788 |
Approved |
0.8194 |
Intermediate Similarity |
NPD6895 |
Approved |
0.8182 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD8053 |
Approved |
0.8171 |
Intermediate Similarity |
NPD8054 |
Approved |
0.8137 |
Intermediate Similarity |
NPD5313 |
Approved |
0.8137 |
Intermediate Similarity |
NPD5312 |
Approved |
0.8025 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.8025 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.8025 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7986 |
Intermediate Similarity |
NPD3109 |
Approved |
0.7986 |
Intermediate Similarity |
NPD3110 |
Approved |
0.795 |
Intermediate Similarity |
NPD2898 |
Approved |
0.7933 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD6297 |
Approved |
0.7922 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD5978 |
Approved |
0.7898 |
Intermediate Similarity |
NPD5977 |
Approved |
0.7895 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.7829 |
Intermediate Similarity |
NPD2421 |
Approved |
0.7829 |
Intermediate Similarity |
NPD2420 |
Approved |
0.7826 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7821 |
Intermediate Similarity |
NPD7110 |
Phase 1 |
0.7821 |
Intermediate Similarity |
NPD7109 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD4474 |
Approved |
0.7793 |
Intermediate Similarity |
NPD4475 |
Approved |
0.7778 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6687 |
Approved |
0.7778 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6688 |
Approved |
0.7763 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7763 |
Intermediate Similarity |
NPD3845 |
Phase 1 |
0.7748 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD6853 |
Approved |
0.7738 |
Intermediate Similarity |
NPD6851 |
Approved |
0.7738 |
Intermediate Similarity |
NPD6618 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD27 |
Approved |
0.773 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7716 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7712 |
Intermediate Similarity |
NPD7598 |
Phase 2 |
0.7682 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7679 |
Intermediate Similarity |
NPD5917 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD6662 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD7258 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7673 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7662 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7647 |
Intermediate Similarity |
NPD2422 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD6875 |
Approved |
0.7643 |
Intermediate Similarity |
NPD6876 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6748 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD7045 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD8095 |
Phase 1 |
0.7613 |
Intermediate Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD7291 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7578 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7574 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7569 |
Intermediate Similarity |
NPD7905 |
Discontinued |
0.7566 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7566 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7551 |
Intermediate Similarity |
NPD554 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7543 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD3977 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4098 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD5087 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1632 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7451 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7447 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7447 |
Intermediate Similarity |
NPD2668 |
Approved |
0.744 |
Intermediate Similarity |
NPD3920 |
Phase 2 |
0.7438 |
Intermediate Similarity |
NPD5720 |
Discontinued |
0.7425 |
Intermediate Similarity |
NPD5708 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD1337 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD1753 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD7132 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD4579 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7371 |
Intermediate Similarity |
NPD3924 |
Approved |
0.7371 |
Intermediate Similarity |
NPD3921 |
Approved |
0.7371 |
Intermediate Similarity |
NPD3922 |
Approved |
0.7371 |
Intermediate Similarity |
NPD3923 |
Approved |
0.7368 |
Intermediate Similarity |
NPD2971 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7280 |
Phase 3 |
0.7368 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD2968 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7281 |
Phase 3 |
0.7365 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7365 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7365 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7361 |
Intermediate Similarity |
NPD1421 |
Approved |
0.7361 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7361 |
Intermediate Similarity |
NPD1420 |
Approved |
0.736 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD2122 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD4727 |
Phase 1 |
0.7329 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7325 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7321 |
Intermediate Similarity |
NPD4498 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD3530 |
Approved |
0.7315 |
Intermediate Similarity |
NPD3531 |
Approved |
0.7315 |
Intermediate Similarity |
NPD3532 |
Approved |
0.7303 |
Intermediate Similarity |
NPD7034 |
Discontinued |
0.7294 |
Intermediate Similarity |
NPD6996 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7292 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7292 |
Intermediate Similarity |
NPD2233 |
Approved |
0.729 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD5754 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD2653 |
Approved |
0.7285 |
Intermediate Similarity |
NPD2492 |
Phase 1 |
0.7285 |
Intermediate Similarity |
NPD2989 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD2986 |
Phase 2 |
0.7284 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7284 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7284 |
Intermediate Similarity |
NPD4585 |
Approved |
0.7278 |
Intermediate Similarity |
NPD6090 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7267 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7254 |
Intermediate Similarity |
NPD2595 |
Approved |
0.7254 |
Intermediate Similarity |
NPD2594 |
Approved |
0.7244 |
Intermediate Similarity |
NPD3692 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7233 |
Intermediate Similarity |
NPD5976 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD44 |
Approved |
0.7226 |
Intermediate Similarity |
NPD6364 |
Approved |
0.7216 |
Intermediate Similarity |
NPD5525 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD3656 |
Approved |
0.7198 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7198 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7197 |
Intermediate Similarity |
NPD2120 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD4210 |
Discontinued |
0.7182 |
Intermediate Similarity |
NPD6612 |
Phase 2 |
0.7181 |
Intermediate Similarity |
NPD5156 |
Approved |
0.7181 |
Intermediate Similarity |
NPD5155 |
Approved |
0.7178 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7178 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7162 |
Intermediate Similarity |
NPD3635 |
Approved |
0.7162 |
Intermediate Similarity |
NPD3637 |
Approved |
0.7162 |
Intermediate Similarity |
NPD3636 |
Approved |
0.7161 |
Intermediate Similarity |
NPD7153 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD5966 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD6873 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD5604 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD3055 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6357 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD4083 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3053 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD3301 |
Approved |
0.7134
|
Intermediate Similarity |
NPD5160 |
Discontinued |